Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MIVT Purchase Of Vascore Would Provide Access To Stent Market

This article was originally published in The Gray Sheet

Executive Summary

Biocompatible coating-developer MIV Therapeutics (MIVT) is making a second attempt to enter the lucrative stent market via its proposed acquisition of Chinese stent manufacturer Vascore Medical

You may also be interested in...

Canadian Biotech To Apply Biocompatible Coating To Drug-Eluting Stents

Biocompatible coating developer MIV Therapeutics (MIVT) says it is in talks with drug manufacturers to discover a compound exhibiting "paclitaxel-like" traits for integration with the firm's emerging stent line

Novartis Faces Another Challenge To Entresto In India

More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.

Cosmetic And Personal Care Trademark Review 24 November, 2020

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts